MaxCyte
NasdaqGS:MXCT
£ 0,76
£-0,01 (-1,30%)
0,76 £
£-0,01 (-1,30%)
End-of-day quote: 03/24/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
-7,31%
5-year Growth Rate
R
0/5
5-year Risk Analysis
O
16,66%
Outlook 12/26
W
43,75%
Margin of safety
T
591%
Analyst Price Target
H
DOWN
50-week EMA Trend

Company Info

EPS Growth 5Y
-9,69%
Revenue growth 5Y
-7,31%
Price growth 5Y
-91,21%
Market Cap
£0,06 B
Long-Term Debt
£0,01 B
Short Interest
3,69%
Annual earnings
03/24/2026 (A)
Dividend
£0,00
Dividend Yield
0,00%
Industry
ISIN Number

MaxCyte Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

£5,25
590.79%
590.79
Last Update: 03/22/2026
Analysts: 3

Highest Price Target £6,75

Average Price Target £5,25

Lowest Price Target £1,66

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
MaxCyte
NasdaqGS:MXCT
-91,21% -91,21% 0,00% -7,31% 0/5 16,66% 43,75% 590,79% DOWN
×